InvestorsHub Logo
Followers 27
Posts 1719
Boards Moderated 0
Alias Born 01/18/2020

Re: None

Friday, 06/11/2021 1:41:05 PM

Friday, June 11, 2021 1:41:05 PM

Post# of 44690
From Pat Dude Pit Bull Pat on Yahoo


hey everybody I just got a message back from relief I'm posting the email

Thank you for your inquiry.

We at Relief are concerned about the dramatic COVID-19 situation in India. There is a major need for additional treatment options for patients with COVID-19 in that country, and we know that the Indian pharmaceutical industry is working on various potential therapies to address this acute situation. Relief was not involved in Biophore’s work on aviptadil. We await with interest the outcome of Biophore’s EUA submission for India.

Relief holds a patent covering potential formulations of RLF-100 in various markets around the world. However, this does not include India.

Kind regards,
Relief Therapeutics